Report copyright - Immunogenicity, safety and efficacy of sequential ......2020/03/06 · CH505 gp140 envelopes (T/F, w53, w78, w100) at six months intervals (Group B1 – IDLV-CH505 alone). The second
Please pass captcha verification before submit form